OBJECTIVES: Better information on the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection is needed in many world areas. STUDY DESIGN: Cross-sectional study of population-based samples of nonpregnant women aged 15 to 44 years in Nigeria, Colombia, Argentina, Vietnam (2 areas), China, Thailand (2 areas), Korea, and Spain. 5,328 consenting women aged 15 to 44 years participated. Exfoliated cervical cells were collected and testing for CT and NG and human papillomavirus (HPV) was done using PCR-based assays. RESULTS: Age-standardized CT prevalence ranged between 0.2% (95% confidence interval, CI: 0.0-0.7%) in Spain and 5.6% (95% CI: 3.4-7.8%) in Nigeria. NG ranged between 0% (with broad CIs) in several areas and 2.6% (95% CI: 1.0-4.2%) in Nigeria. Prevalence of CT in all areas combined was greater in women aged 15 to 24 (4.5; 95% CI: 3.4-5.8%) than 25 to 44 (2.6; 95% CI: 2.1-3.1%), whereas NG prevalence was similar in the 2 age groups (0.3%). The only significant risk factors were NG infection (for CT), CT infection (for NG) and infection with high-risk HPV types (for both). CONCLUSIONS: The prevalence of CT and, most notably, NG was relatively low in a variety of countries. Our findings, however, do not apply to subsets of high-risk women who are likely to be underrepresented in our population-based samples.
OBJECTIVES: Better information on the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection is needed in many world areas. STUDY DESIGN: Cross-sectional study of population-based samples of nonpregnant women aged 15 to 44 years in Nigeria, Colombia, Argentina, Vietnam (2 areas), China, Thailand (2 areas), Korea, and Spain. 5,328 consenting women aged 15 to 44 years participated. Exfoliated cervical cells were collected and testing for CT and NG and human papillomavirus (HPV) was done using PCR-based assays. RESULTS: Age-standardized CT prevalence ranged between 0.2% (95% confidence interval, CI: 0.0-0.7%) in Spain and 5.6% (95% CI: 3.4-7.8%) in Nigeria. NG ranged between 0% (with broad CIs) in several areas and 2.6% (95% CI: 1.0-4.2%) in Nigeria. Prevalence of CT in all areas combined was greater in women aged 15 to 24 (4.5; 95% CI: 3.4-5.8%) than 25 to 44 (2.6; 95% CI: 2.1-3.1%), whereas NG prevalence was similar in the 2 age groups (0.3%). The only significant risk factors were NG infection (for CT), CT infection (for NG) and infection with high-risk HPV types (for both). CONCLUSIONS: The prevalence of CT and, most notably, NG was relatively low in a variety of countries. Our findings, however, do not apply to subsets of high-risk women who are likely to be underrepresented in our population-based samples.
Authors: Mayara Costa Mansur Tavares; Jamilly Lopes de Macêdo; Sérgio Ferreira de Lima Júnior; Sandra de Andrade Heráclio; Melânia Maria Ramos Amorim; Maria de Mascena Diniz Maia; Paulo Roberto Eleutério de Souza Journal: Mol Biol Rep Date: 2014-01-07 Impact factor: 2.316
Authors: Jennifer S Smith; Adam K Lewkowitz; You-Lin Qiao; Jia Ji; Shangying Hu; Wen Chen; Rong Zhang; Kai Li Liaw; Mark Esser; Frank J Taddeo; Robert G Pretorius; Jerome L Belinson Journal: Int J Cancer Date: 2012-01-27 Impact factor: 7.396
Authors: Jennifer Tsui; Hector P Rodriguez; Gilbert C Gee; Loraine A Escobedo; Gerald F Kominski; Roshan Bastani Journal: Cancer Causes Control Date: 2013-09-17 Impact factor: 2.506
Authors: Jennifer S Smith; Danielle M Backes; Michael G Hudgens; Robert C Bailey; Giovanni Veronesi; Martijn Bogaarts; Kawango Agot; J O Ndinya-Achola; Ian Maclean; Walter Agingu; Chris J L M Meijer; Stephen Moses; Peter J F Snijders Journal: Int J Cancer Date: 2010-01-15 Impact factor: 7.396
Authors: Shelagh M Redmond; Karin Alexander-Kisslig; Sarah C Woodhall; Ingrid V F van den Broek; Jan van Bergen; Helen Ward; Anneli Uusküla; Björn Herrmann; Berit Andersen; Hannelore M Götz; Otilia Sfetcu; Nicola Low Journal: PLoS One Date: 2015-01-23 Impact factor: 3.240
Authors: Joanna Crichton; Matthew Hickman; Rona Campbell; Harriet Batista-Ferrer; John Macleod Journal: BMC Public Health Date: 2015-07-30 Impact factor: 3.295